Mobile App

Google Play Apple Store
Clinical Clips - Advancements in Pediatric ITP Management: Insights from EHA 2024
AMA/ABS/ANCC - Clinical Clips
Immune thrombocytopenic purpura (ITP) is an acquired autoimmune disease characterized by a low platelet count, purpura, and hemorrhagic episodes caused by antiplatelet autoantibodies. Diagnosis is typically made by excluding the known causes of thrombocytopenia. Recent advancements in pediatric ITP treatment show promise for personalized medicine and better outcomes. Healthcare providers can improve treatment decisions and patient quality of life by staying updated on these developments. This clinical clip will provide expert interpretation of new and emerging data on the pathophysiology, diagnosis and treatment of pediatric ITP presented at the European Hematology Association (EHA) 2024 Hybrid Congress, June 13-16, Madrid, Spain.
Review the activity to claim AMA/ABS/ANCC credit after completion of the brief Post-Test/Evaluation(s).

Cindy Neunert, MD Cindy Neunert, MD
Associate Professor of Pediatrics
Columbia University Irving Medical Center
New York, New York

*This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings of the 2024 EHA Annual Congress.
Supported by an independent educational grant from Sobi, Inc.

Launch Date: June 16, 2024
Release Date: June 16, 2024
Expiration Date: May 31, 2025

Mini Module


Change Settings